The relationship between emotional functioning of the EORTC QLQ-C30 and a measure of anxiety and depression (HADS) in cancer patients

8Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Objectives: In order to reduce suffering in cancer patients from answering different questionnaires, this study aimed to explore whether the emotional functioning (derived from subscale of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire-EORTC QLQ-C30) could quantify anxiety and depression in patients with different carcinomas. Methods: Sample of patients with gastrointestinal cancer attending to Tehran Cancer Institute were studied. Patients were asked to complete two questionnaires: the emotional functioning (EF-derived from the EORTC QLQ-C30) and the hospital anxiety and depression scale (HADS). The Pearson’s correlation coefficient (r) and logistic regression analyses were performed in order to examine the association between emotional functioning (EF), anxiety, and depression. Results: In total 137 patients with gastrointestinal cancer were included in the study. The mean age of patients was 54.6 (SD = 13.8) years old; most were married (87%), male (55.5%), and without any normal education (55.5%). The mean emotional functioning score was 69.3 (SD = 27.3) and it was 7.7 (SD = 4.5) for anxiety and 8.5 (SD = 3.9) for depression. Significant negative correlations were found between EF subscale of the EORTC QLQ-C30 and both subscales of the HADS (Anxiety: r =-0.62, P < 0.0001; Depression: r =-0.54, P < 0.0001). The results obtained from logistic regression analysis showed strong associations between emotional functioning, anxiety, and depression (odds ratio for anxiety: 0.94, 95%; CI: 0.92-0.96, P < 0.0001; odds ratio for depression: 0.96, 95%; CI: 0.94-0.98; P < 0.0001). No other variables studied showed significant results. Conclusions: The findings demonstrated that emotional functioning subscale of the EORTC QLQ-C30 covers both anxiety and depression. Indeed it is robust to use emotional functioning subscale to assess psychological distress in cancer patients.

References Powered by Scopus

The Hospital Anxiety and Depression Scale

38337Citations
N/AReaders
Get full text

The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology

13313Citations
N/AReaders
Get full text

The validity of the Hospital Anxiety and Depression Scale: An updated literature review

8346Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma

35Citations
N/AReaders
Get full text

Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma

11Citations
N/AReaders
Get full text

Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tavoli, A., Tavoli, Z., & Montazeri, A. (2019). The relationship between emotional functioning of the EORTC QLQ-C30 and a measure of anxiety and depression (HADS) in cancer patients. International Journal of Cancer Management, 12(7). https://doi.org/10.5812/ijcm.94568

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

60%

Professor / Associate Prof. 2

20%

Lecturer / Post doc 2

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

70%

Nursing and Health Professions 2

20%

Computer Science 1

10%

Save time finding and organizing research with Mendeley

Sign up for free